Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Vural

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Characteristics of The Medicines Which Have Annual Average Highest Amount Of Sales Of Between Years 2008-2013A Akbulat, E Dogan, S Babacan, et al.
Frontiers in Pharmacology|August 13, 2016
Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the FutureWinnie de Bruijn, Cristina Ibáñez, Pia Frisk, et al.
Expert Review of Clinical Pharmacology|December 10, 2014
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?Brian Godman, Rickard E Malmström, Eduardo Diogene, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Characteristics of The Medicines Which Have Annual Average Highest Amount Of Sales Of Between Years 2008-2013A Akbulat, E Dogan, S Babacan, et al.
Frontiers in Pharmacology|August 13, 2016
Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the FutureWinnie de Bruijn, Cristina Ibáñez, Pia Frisk, et al.
Expert Review of Clinical Pharmacology|December 10, 2014
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?Brian Godman, Rickard E Malmström, Eduardo Diogene, et al.
Pageof 5